{"disease":{"id":"tick-borne-encephalitis","name":"tick borne encephalitis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT05941546","title":"Tick-borne Encephalitis Virus Research in Limousin","phase":"","overall_status":"COMPLETED","enrollment_count":878,"lead_sponsor_name":"University Hospital, Limoges","has_results":false},{"nct_id":"NCT03958058","title":"Tick-borne Encephalitis and Possible Borrelial Serology","phase":"","overall_status":"COMPLETED","enrollment_count":690,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT05607394","title":"Prevalence of Tick-borne Encephalitis in the Pediatric Population Treated at the HUS and Characterization of Confirmed Pediatric Cases","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT01562444","title":"Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":206,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06859619","title":"Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":183,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT04648241","title":"Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":165,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT05138055","title":"The NOrwegian Tick-borne Encephalitis Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":153,"lead_sponsor_name":"Sykehuset Telemark","has_results":false},{"nct_id":"NCT07191223","title":"Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT03956446","title":"Tick-borne Encephalitis and Borrelial Antibodies in Serum","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT04017052","title":"Application of a TBE-Vaccine in Obese Persons","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":73,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT01031537","title":"Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":69,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT07377253","title":"First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":18,"lead_sponsor_name":"Giuseppe Pantaleo","has_results":false},{"nct_id":"NCT03932448","title":"Fever After Tick Bite Study","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Göteborg University","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}